Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC21268 | MAC173979 |
MAC173979 is a novel time-dependent inhibitor of p-aminobenzoic acid biosynthesis with IC50 of 30 uM, represents the first PABA biosynthesis inhibitor with activity against Gram-negative bacteria..
More description
|
![]() |
DC21267 | MAC168425 |
MAC168425 is a novel antibacterial inhibitor that interferes with glycine metabolism in E coli..
More description
|
![]() |
DC21266 | MAC13772 |
MAC13772 is a potent inhibitor of BioA with an IC50 of 250 nM, a novel antibacterial inhibitor that selectively inhibits PABA biosynthesis in M tuberculosis..
More description
|
![]() |
DC21339 | MAC1 |
MAC1 (Monastrol Antagonizing Compound 1) is a small molecule that can rescue spindle bipolarity in cells lacking Eg5 activity.
More description
|
![]() |
DC21265 | M-525 |
M-525 is a first-in-class, highly potent, irreversible small-molecule inhibitor of the menin-MLL interaction with binding IC50 of 3.3 nM in FP assays.
More description
|
![]() |
DC21264 | M4284 |
M4284 (M-4284) is a high-affinity biphenyl mannoside FimH inhibitor with HAI of 16 nM in hemagglutination assay.
More description
|
![]() |
DC23382 | L-α-Hydroxyglutaric acid disodium salt |
L-α-Hydroxyglutaric acid disodium salt (L-2-Hydroxyglutarate.
More description
|
![]() |
DC21262 | LYS228 |
LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml.
More description
|
![]() |
DC20440 | LYPLAL1-IN-11 |
LYPLAL1-IN-11 is a potent, selective, covalent inhibitor of lysophospholipase-like 1 (LYPLAL1) with IC50 of 6 nM.
More description
|
![]() |
DC21260 | LY-83583 |
LY-83583 is an inhibitor of soluble guanylate cyclase (sGC) and of cGMP production, inhibits sGC in human platelets with IC50 of 2 uM.
More description
|
![]() |
DC23636 | LY-503430 |
LY-503430 is a novel AMPA receptor (AMPAR) potentiator that selectively enhances glutamate-induced calcium influx into HEK293 cells transfected with human GLUA1, GLUA2, GLUA3, or GLUA4 AMPA receptors with EC50 of 0.1-4 uM.
More description
|
![]() |
DC7459 | LY500307 |
LY500307 is a potent, selective estrogen receptor β agonist with EC50 of 0.66 nM, 32-fold selectivity against estrogen receptor α. Phase 2.
More description
|
![]() |
DC22420 | LY-487379 hydrochloride |
LY-487379 is a potent, selective positive allosteric modulator of mGluR2 (EC50=0.27 uM) without activity at mGluR3.
More description
|
![]() |
DC23597 | LY-404187 |
LY-404187 is a potent, selective, positive allosteric modulator of AMPA receptor (AMPAR) with EC50 of 1.3 uM.
More description
|
![]() |
DC23829 | LY379196 |
LY379196 is a highly specific PKCβ inhibitor with IC50 of 30-50 nM for PKCβI and PKCβII, displays >10-fold selectivity of PKCα, δ, η, and γ (>600 nM).
More description
|
![]() |
DC11323 | LY354740 |
LY354740 is an agonist of the group II metabotropic glutamate receptor (mGluR) subtypes mGluR2 and mGluR3 (Kis = 99 and 94 nM, respectively).
More description
|
![]() |
DC9314 | LY 344864 |
LY344864 is a selective receptor agonist with an affinity of 6 nM (Ki) at the recently cloned 5-HT1F receptor.
More description
|
![]() |
DC12261 | LY3295668 (AK-01) |
LY3295668 is a potent, orally active and highly specific Aurora-A kinase inhibitor, with Ki values of 0.8 nM and 1038 nM for AurA and AurB, respectively.
More description
|
![]() |
DC12507 | LY3143921 |
LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively..
More description
|
![]() |
DC7776 | LY-3039478 |
LY3039478 a orally bioavailable, novel small molecule Notch inhibitor with an IC50 of ~1nM in most of the tumor cell lines tested.
More description
|
![]() |
DC21340 | LY 2979165 |
LY2979165 (MP-101) is the alanine prodrug of LY2812223, a selective orthosteric mGlu2 receptor agonist.
More description
|
![]() |
DC11681 | LY2922470 |
LY2922470 (LY-2922470) is a potent, selective, orally available GPR40 agonist with EC50 of 7 nM.
More description
|
![]() |
DC22595 | LY2857785 |
LY2857785 is a potenrt, reversible and ATP-competitive CDK9 inhibitor with IC50 of 11 nM, also inhibits CDK8 (IC50=16 nM) and weakly inhibits CSK7 (IC50=246 nM).
More description
|
![]() |
DC23444 | LY2624803 |
LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia..
More description
|
![]() |
DC22140 | LY2623091 |
LY2623091 (LY-2623091) is an orally administered mineralocorticoid receptor antagonist for the treatment of essential hypertension and chronic kidney disease..
More description
|
![]() |
DC12130 | LY223982 |
LY223982 is a potent and specific inhibitor of leukotriene B4 receptor, with an IC50 of 13.2 nM against [3H]LTB4 binding to LTB4 receptor.
More description
|
![]() |
DC2045 | LY2183240 |
LY2183240 is a novel and highly potent blocker of anandamide uptake (IC50 = 270 pM).
More description
|
![]() |
DC7189 | LY-2109761 |
LY2109761 is a novel selective TGF-β receptor type I/II (TβRI/II) dual inhibitor with Ki of 38 nM and 300 nM, respectively; shown to negatively affect the phosphorylation of Smad2.
More description
|
![]() |
DC23633 | LY 392098 |
LY 392098 is a selective, potent and centrally active positive allosteric modulator of AMPAR.
More description
|
![]() |
DC21256 | LY 2318912 |
LY 2318912 is a potent, competitive, small molecule inhibitor of anandamide uptake with IC50 of 7.27 nM, shows high affinity against anandamide transporter binding site with Kd o f7.62 nM.
More description
|
![]() |